Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...
Big changes have come to Medicare’s prescription drug coverage, known as Part D, in 2026 that could affect how you pay for ...
Access to GLP-1 weight loss drugs could improve the long-term health and well-being for millions of Americans.
The new ID update aims to reduce fraud and streamline Medicare processes online. ID.me announced its new contract with the Centers for Medicare & Medicaid Services (CMS) to streamline processes on ...
The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies. | The Trump administration has unveiled yet another new payment model, this one ...
CMS’ new ACCESS model, slated to begin on July 1, aims to shift traditional Medicare fee-for-service toward value-based care ...
CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. The announcement comes weeks following the White House’s ...
The Trump administration has revealed what comes next when the ACO REACH model concludes at the end of 2026. | The Trump ...
Americans enrolled in Medicare will pay about 50% less out of pocket in 2026 for some drugs including Pfizer and Bristol ...
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models.
The experiments would cut the prices of some drugs to bring them in line with what other countries pay, saving Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback